Cover -- Title -- Copyright -- Contents -- Contributors -- Preface -- Acknowledgments -- Share The Advanced Practice Nurse Cardiovascular Clinician -- Section I: Overview of Cardiovascular Care -- Chapter 1: The Interprofessional Team: Focus on Quality -- Health Care Delivery System Redesign -- Interprofessional Collaboration -- Cardiovascular Team Members -- Techniques for Implementation of Interdisciplinary Collaboration with the Health Care Team -- Focus on Quality -- Chapter 2: The Cardiovascular History -- Identifying Information -- Chief Concern -- History of Present Illness -- Past Medical History -- Past Procedural and Surgical History -- Review of Systems -- Allergies and Reactions -- Medication History -- Health Promotion and Disease Prevention -- Collaborators -- Family History -- Social History -- Cognitive and Functional Abilities -- Patient Expectations, Goals, and Values -- Cardiovascular Risk Stratification and Diagnostic Reasoning -- Coding the Visit -- Privilege and Challenges -- Chapter 3: The Comprehensive Cardiovascular Physical Examination -- The General Survey -- Cardiovascular Assessment -- Cardiovascular-Related Findings in Other Body Areas and Systems -- Functional Capacity -- Population Considerations -- Billling and Coding -- Chapter 4: Preoperative Cardiovascular Risk Assessment and Evaluation for Noncardiac Surgery -- Preoperative Interview -- Preoperative Physical Examination -- Preoperative Risk Evaluation -- Cardiopulmonary Diagnostic Testing -- Perioperative Management -- Section II: Chronic Cardiovascular Conditions -- Chapter 5: Hypertension -- Classifications -- Stages of Hypertension -- Pathophysiology -- Complications of Hypertension -- Clinical Presentation -- Physical Examination -- Diagnostic Testing -- Secondary Hypertension -- Diagnosis of Hypertension -- Therapeutic Management of Hypertension.

Pharmacologic Therapy -- Follow-Up -- Referral -- Chapter 6: Lipid Metabolism Disorders -- Pathophysiology -- Classification Systems -- Secondary Causes of Lipoprotein Abnormalities -- Clinical Presentation -- Physical Examination -- Screening -- Diagnostic Laboratory Evaluation -- Risk Stratification -- Therapeutic Lifestyle Modifications -- Pharmacologic Therapy -- Special Considerations -- Follow-Up and Referrals -- Chapter 7: Diabetes and the Metabolic Syndrome -- Pathophysiology -- The Metabolic Syndrome -- Clinical Presentation -- Physical Examination -- Diagnostic Testing -- Nonpharmacological Management -- Pharmacological Therapy -- Follow-Up and Referrals -- Chapter 8: Chest Pain -- Etiologies of Cardiac Chest Pain -- Etiologies of Non-Cardiac Chest Pain -- Chapter 9: Stable Ischemic Heart Disease -- Pathophysiology -- Clinical Presentation -- Health History -- Physical Examination -- Cardiac Risk Assessment in the Asymptomatic Adult -- Noninvasive Diagnostic Testing -- Cardiac Risk Assessment in the Symptomatic Adult -- Diagnostic Evaluation -- Therapeutic Management of SIHD -- Nonpharmacologic Management -- Pharmacologic Therapy -- Advanced Therapeutic Management of SIHD -- Special Considerations for SIHD -- Chapter 10: Valvular Heart Disease -- The Mitral Valve -- Mitral Valve Prolapse -- Chronic MR -- Mitral Stenosis -- The Aortic Valve -- Aortic Valve Regurgitation -- Aortic Valve Stenosis -- The Tricuspid Valve -- Tricuspid Valve Regurgitation -- The Pulmonary Valve -- Pulmonary Valve Regurgitation -- Pulmonary Valve Stenosis -- The Prosthetic Valve -- Chapter 11: Chronic Heart Failure -- Pathophysiology -- Cardiomyopathy -- HF Classification -- Diagnosis -- Diagnostic Evaluation -- HF Risk Stratification -- Nonpharmacologic Management -- Pharmacologic Therapy -- Cardiovascular Implantable Electronic Device Therapy.

Clinical Challenges -- Advanced HF -- Referrals and Consultations -- Advanced HF Management Programs -- Left Ventricular Assist Device -- Heart Transplant -- Section III: Cardiac Electrophysiology -- Chapter 12: Common Electrophysiology Presentations -- Palpitations -- Syncope -- Chest Pain -- Fatigue and Dyspnea -- Genetic Syndromes -- Chapter 13: Common Conditions for Electrophysiology Referral -- Atrial Fibrillation -- AF Management -- Bradycardia -- Supraventricular Tachycardia -- Atrial Flutter -- Cardiomyopathy and Heart Failure -- Ventricular Arrhythmias -- Chapter 14: Electrophysiology Diagnostic Studies and Cardiovascular Implanted Electronic Devices -- Electrophysiology Diagnostic Studies and Tests -- Cardiovascular Implanted Electronic Devices -- Section IV: Vascular Disorders -- Chapter 15: Peripheral Arterial Disease -- Pathophysiology -- Risk Factors -- Diagnosis -- Natural History -- Therapeutic Interventions -- Chapter 16: Abdominal Aortic Aneurysm -- Pathophysiology -- Risk Factors -- Diagnosis -- Screening -- Therapeutic Interventions -- Special Populations -- Patient Education -- Section V: Acute Cardiovascular Conditions -- Chapter 17: Hypertensive Emergencies -- Pathophysiology -- Clinical Presentation -- Health History -- Physical Examination -- Diagnostic Testing -- Management -- Chapter 18: Acute Coronary Syndrome -- Pathophysiology -- Universal Classification of MI -- Location, Type, and Extent of Infarction -- Clinical Recognition and Presentation -- Evaluation and Risk Stratification -- Health History -- Physical Examination -- Diagnostic Testing -- Diagnosis of ACS -- ST-Elevation Myocardial Infarction -- Takotsubo Cardiomyopathy -- Non-ST-Segment Elevation Myocardial Infarction -- Negative Prognostic Indicators -- Therapeutic Management -- Stemi Management -- NSTE-ACS Management -- Medication Management for ACS Patients.

Medication Adjustments in Women and the Older Adult -- Pre-Discharge Risk Assessment -- Post-Discharge Management of ACS Patients -- Complications of ACS -- Chapter 19: Acute Decompensated Heart Failure -- Pathophysiology -- Clinical Presentation -- Physical Examination -- Diagnostic Testing -- Risk Stratification -- Management -- Ultrafiltration -- Fluid and Sodium Restriction -- Mechanical Circulatory Support -- Transitions in Care -- Chapter 20: Shock States: Cardiogenic and Obstructive -- Cardiogenic Shock -- Obstructive Shock -- Chapter 21: Aortic Dissection -- Pathophysiology -- Diagnosis -- Clinical Presentation -- Physical Examination -- Diagnostic Testing -- Management -- Complications of Aortic Dissection -- Follow-Up -- Chapter 22: Pericarditis and Infective Endocarditis -- Pericarditis -- Infective Endocarditis -- Chapter 23: Syncope -- Pathophysiology -- Etiology -- Diagnosis -- Clinical Presentation -- Physical Examination -- Diagnostic Testing -- Risk Stratification -- Management -- Chapter 24: Sudden Cardiac Death and Cardiac Arrest -- Etiology -- Diagnosis -- Clinical Presentation -- Physical Examination -- Diagnostic Testing -- Management -- Predicting Neurologic Outcomes -- Long-Term Management of CA Survivors -- ICDs as Primary Prevention for SCD -- Section VI: Cardiovascular Diagnostics -- Chapter 25: Diagnostic Laboratory Evaluations -- Serum Chemistries -- Measures of Kidney Function -- Glucose Metabolism -- Measures of Hepatic Function -- Hematologic Studies -- Coagulation Studies -- Lipid Metabolism -- Inflammatory Markers -- Other Related Studies -- Cardiac Biomarkers -- Therapeutic Drug Monitoring -- Cardiac Genetic Testing -- Urine Studies -- General Recommendations -- Chapter 26: Noninvasive Diagnostic Testing: Electrocardiograph and Ultrasound -- Electrocardiograph Tests -- Ultrasound Tests.

Chapter 27: Noninvasive Diagnostic Testing: Radiographic and Nuclear Imaging -- Radiographic Tests -- Nuclear Imaging -- Clinical Decision Making -- Section VII: Cardiovascular Therapeutics and Interventions -- Chapter 28: Integration of Therapeutic Lifestyle Interventions -- Nutritional Interventions -- Weight Management and Weight Loss -- Smoking Cessation and Substance Abuse -- Physical Activity -- Complementary Therapies -- Cardiac Rehabilitation -- Sexual Function -- Chapter 29: Pharmacotherapeutics of Hypertension and Hypertensive Emergencies -- Pharmacotherapeutics of Chronic Hypertension -- Pharmacotherapeutics of Hypertensive Emergencies -- Chapter 30: Pharmacotherapeutics of Hyperlipidemia -- Pathophysiology -- HMG-CoA Reductase Inhibitors (Statins) -- Nicotinic Acid -- Bile Acid Sequestrants -- Fibrates -- Cholesterol Absorption Inhibitor -- Fish Oil -- Chapter 31: Antithrombotic Therapy and Pharmacotherapeutics of Thrombotic Disease States -- Pharmacotherapeutics of Thromboembolic Disease States -- Hemostasis -- Pharmacology of the Antithrombotic Agents -- Pharmacotherapy of Thromboembolic Disease States -- Chapter 32: Pharmacotherapeutics of Ischemic Heart Disease -- Chronic Stable Angina -- Acute Coronary Syndromes: UA, NSTEMI, and STEMI -- Dual Antiplatelet Therapy -- Anticoagulation -- GP IIB/IIIA Inhibitors -- High-Dose Statin Therapy -- Beta Adrenergic Receptor Blockers -- Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers -- Protease-Activated Receptor-1 -- St-Segment Elevation Myocardial Infarctions -- CABG Post-Angiography -- Chapter 33: Pharmacotherapeutics of Heart Failure and Acute Decompensated Heart Failure -- Pharmacologic Therapy: Chronic HF -- Pharmacotherapy of HF Management -- Acute Decompensated Heart Failure -- Chapter 34: Pharmacotherapeutics of Cardiac Arrhythmias -- Class I -- Class II.

Class III.